Leicestershire Partnership NHS Trust 2024

Dear Wendy Micklewright,

Request under Freedom of Information Act 2000 – Ref: FOI/2526/SG16564

Thank you for your request for information under the Freedom of Information Act 2000, received on 15^th May 2025. Please find below our response to your request:

REQUEST:

Please provide Electro Convulsive Treatment (ECT) information under the FOI act to the following questions: -

1.Please supply patient’s information ECT leaflet

OUR RESPONSE: Please see attached.

2.Please supply patient ECT consent form

OUR RESPONSE: Please see attached.

3.Please supply any ECT reports/investigations

OUR RESPONSE: I can confirm the Trust holds the information you have requested. However, we are withholding this information since we consider the exemption under Section 40(2) of the Freedom of Information Act 2000 applies to it, as it constitutes the personal data of individuals and disclosure would, therefore, breach data protection principle(a). S40(2) is an absolute exemption and, as such, we have not carried a public interest test

4.How many ECT in 2024?

OUR RESPONSE: 52 patients.

5.What proportion of patients were men/women?

OUR RESPONSE: Female 39 / Male 13.

6.How old were they?

OUR RESPONSE:

18 - 64: 16

Over 65: 36

7.What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")?

OUR RESPONSE: From our preliminary assessment, we estimate that compliance with your request would exceed the appropriate costs limit under section 12 of the Freedom of information Act 2000, currently £450, as we do not centrally record the information being requested and this would require a manual review to determine.

8.How many people covered by the equality act - specific protected characteristics - excluding age + gender - received ECT ?

9.How many people were offered talking therapy prior to ECT ?

OUR RESPONSE: 9.

10.How many were receiving ECT for the first time?

OUR RESPONSE: 17.

11.How many patients consented to ECT?

OUR RESPONSE: 14.

12.How many ECT complaints were investigated outside the NHS ?

OUR RESPONSE: 0.

13.How many patients died during or 1 month after ECT and what was the cause (whether or not ECT was considered the cause)?

14.How many patients died within 6 months after ECT and what was the cause (whether or not ECT was considered the cause)?

15.How many patients died by suicide within 6 months of receiving ECT (whether or not ECT was considered the cause)?

16.How many patients have suffered complications during and after ECT and what were those complications?

17.Have there been any formal complaints from patients/relatives about ECT?

OUR RESPONSE: 4.

18.If so, what was their concerns?

OUR RESPONSE: I can confirm the Trust holds the information you have requested. However, we are withholding this information since we consider the exemption under Section 40(2) of the Freedom of Information Act 2000 applies to it, as it constitutes the personal data of individuals and disclosure would, therefore, breach data protection principle(a). S40(2) is an absolute exemption and, as such, we have not carried a public interest test.

19.How many patients report memory loss/loss of cognitive function?

20.What tests are used to assess memory loss/loss of cognitive function?

OUR RESPONSE: Montreal Cognitive Assessment Tool (MOCA) and a medical opinion.

21.Have MRI or CT scans been used before and after ECT?

OUR RESPONSE: No.

22.If so, what was the conclusion?

OUR RESPONSE: Not applicable.

23.How does the Trust plan to prevent ECT in the future?

OUR RESPONSE: Not applicable.

Please provide restraints information under the FOI act to the following questions: -

1.Please supply any Restraints/investigations

2.How many RESTRAINTS in 2024?

OUR RESPONSE: 1675.

3.What proportion of patients were men/women?

OUR RESPONSE: Female 1192 / Male 483.

4.How old were they?

OUR RESPONSE:

Under 18: 390.

18 – 64 : 982.

Over 65: 303.

5.What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")?

OUR RESPONSE: This detailed information is exempt under S40(2) of the Freedom of Information Act, as it may be possible to identify individuals and disclosure would, therefore, breach data protection principle(a). S40(2) is an absolute exemption and, as such, we have not carried a public interest test. However, in an effort to be helpful, please see table below for recorded ethnicity categories for recorded restraints. Please note, exact small numbers have been redacted.

Category	Number of patients
Unknown	101
Asian or Asian British - Any other Asian background	26
Asian or Asian British - Indian	55
Asian or Asian British - Pakistani	≤10
Black or Black British - African	30
Black or Black British - Any other Black background	≤10
Black or Black British - Caribbean	39
Mixed - Any other mixed background	28
Mixed - White and Asian	≤10
Mixed - White and Black African	≤10
Mixed - White and Black Caribbean	≥10
Not Stated	37
Other Ethnic Groups - Any other ethnic group	20
Other Ethnic Groups - Chinese	≤10
White - Any other White background	64
White - British	1233
White - Irish	≤10

6.How many people covered by the equality act - specific protected characteristics - excluding age + gender - were restrainted?

7.How many RESTRAINTS were investigated outside the NHS?

OUR RESPONSE: There have been no external investigations into any restraints that have taken place within the trust.

8.How many patients died during or 1 month after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)?

OUR RESPONSE: No patients died during restraint. To establish further information would exceed the appropriate costs limit under section 12 of the Freedom of information Act 2000, currently £450, as we do not centrally record the information being requested and this would require a manual review to determine.

9.How many patients died within 6 months after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)?

10.How many patients died by suicide within 6 months of receiving RESTRAINTS (whether or not RESTRAINTS was considered the cause)?

11.How many patients have suffered complications during and after RESTRAINTS and what were those complications?

12.Have there been any formal complaints from patients/relatives about RESTRAINTS?

OUR RESPONSE: No.

13.If so, what was their concerns?

OUR RESPONSE: Not applicable.

14.Are counts of forced injections available? if so how many people were forcible injected ?

15.How does the Trust plan to reduce restraints in the future?

OUR RESPONSE: The Trust has a least restrictive practice plan that is reviewed yearly aimed at supporting the reduction in the use of restraint and seclusion. the trust train clinical staff in preventing the use of restraint and seclusion by alternative methods utilising safewards and positive behaviour support approaches and if restraint is required it is done by trained staff using safety interventions training. all restraint and seclusion incidents are monitored monthly in services and at the trust least restrictive practice group.

16.How many of these restraints were face down restraints?

OUR RESPONSE: From our preliminary assessment, we estimate that compliance with your request would exceed the appropriate costs limit under section 12 of the Freedom of information Act 2000, currently £450, as we do not centrally record the information being requested and this would require a manual review to determine.

Please provide SECLUSION information under the FOI act to the following questions: -

1.Please supply any SECLUSION reports/investigations

2.How many SECLUSIONS in 2024?

OUR RESPONSE: 112.

3.What proportion of patients were men/women?

OUR RESPONSE: Female 48 / Male 64.

4.How old were they?

OUR RESPONSE:

Under 18: ≤5

18 – 64 : 111.

5.What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")?

OUR RESPONSE: This detailed information is exempt under S40(2) of the Freedom of Information Act, as it may be possible to identify individuals and disclosure would, therefore, breach data protection principle(a). S40(2) is an absolute exemption and, as such, we have not carried a public interest test. However, in an effort to be helpful, please see table below for recorded ethnicity categories for recorded seclusion. Please note, exact small numbers have been redacted.

Category	Number of patients
Unknown	8
Asian or Asian British - Any other Asian background	≤10
Asian or Asian British - Indian	≤10
Asian or Asian British - Pakistani	≤10
Black or Black British - African	≤10
Black or Black British - Any other Black background	≤10
Black or Black British - Caribbean	≤10
Mixed - Any other mixed background	≤10
Mixed - White and Black African	≤10
Mixed - White and Black Caribbean	≥10
Not Stated	6
Other Ethnic Groups - Any other ethnic group	2
White - Any other White background	11
White - British	43

6.How many people covered by the equality act - specific protected characteristics - excluding age + gender - were secluded ?

7.How many SECLUSIONS were investigated outside the NHS?

OUR RESPONSE: There have been no external investigations into any seclusions that have taken place within the Trust.

8.How many patients died during or 1 month after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)?

OUR RESPONSE: No patients died during seclusion. To establish further information would exceed the appropriate costs limit under section 12 of the Freedom of information Act 2000, currently £450, as we do not centrally record the information being requested and this would require a manual review to determine.

9.How many patients died within 6 months after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)?

10.How many patients died by suicide within 6 months of receiving SECLUSION (whether or not SECLUSION was considered the cause)?

11.How many patients have suffered complications during and after SECLUSION and what were those complications?

12.Have there been any formal complaints from patients/relatives about SECLUSION?

OUR RESPONSE: 0.

13.If so, what was their concerns?

OUR RESPONSE: Not applicable.

14.How does the Trust plan to reduce SECLUSIONS in the future?

Please provide MEDICATION ERRORS information under the FOI act to the following questions: -

1.Please supply any MEDICATION ERRORS reports/investigations

2.How many MEDICATION ERRORS in 2024?

OUR RESPONSE: 422.

3.What proportion of patients were men/women?

4.How old were they?

5.What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")?

6.How many people covered by the equality act - specific protected characteristics - excluding age + gender - endured medication errors ?

7.How many MEDICATION ERRORS were investigated outside the NHS ?

8.How many patients died during or 1 month after MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)?

9.How many patients died within 6 months after MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)?

10.How many patients died by suicide within 6 months of receiving MEDICATION ERRORS (whether or not MEDICATION ERRORS was considered the cause)?

11.How many patients have suffered complications during and after MEDICATION ERRORS and what were those complications?

12.Have there been any formal complaints from patients/relatives about MEDICATION ERRORS?

OUR RESPONSE: 17.

13.If so, what was their concerns?

14.How does the Trust plan to prevent MEDICATION ERRORS in the future?

OUR RESPONSE: The Trust is committed to continuously improving medication safety. All medication errors are thoroughly reviewed in relation to systems and processes. We apply quality improvement methodologies to identify root causes and implement changes to practice and systems that help prevent similar errors from recurring.

In addition, we have a robust process for tracking, monitoring, and reporting medication-related incidents. This allows us to identify patterns, share learning, and take proactive steps to enhance patient safety.

The Trust is in the process of recruiting a Medication Safety Officer, whose remit is to lead on medication safety initiatives, oversee the review of medication incidents, support learning and improvement, and work collaboratively with clinical teams to implement safer prescribing, administration, and monitoring practices.

I trust this response is helpful to you.

However, if you are dissatisfied with the handling of your request, you have the right to ask for an internal review. Requests for an internal review should be submitted within two months of the date of receipt of the response to your original request and should be addressed to: Data Protection Officer, Data Privacy Team, Room 500, Rutland Building, County Hall, Leicester Road, Glenfield, Leicestershire, LE3 8RA.

If you remain dissatisfied with the handling of your request, you have a right of appeal to the Information Commissioner at: The Information Commissioner's Office, Wycliffe House, Water Lane, Wilmslow, Cheshire SK9 5AF. Phone: 0303 123 1113. Website: www.ico.gov.uk . There is no charge for making an appeal.

If you require any further assistance, please do not hesitate to contact me. Please remember to quote the reference number above in any communications.

Yours sincerely,

Data Privacy Team.

Yours sincerely,

Data Privacy Team

Leicestershire Partnership NHS Trust.